Systemic therapy of hepatocellular carcinoma: Are we making progress?

Article Properties
Cite
Roxburgh, Patricia, and T. R. Jeffry Evans. “Systemic Therapy of Hepatocellular Carcinoma: Are We Making Progress?”. Advances in Therapy, vol. 25, no. 11, 2008, pp. 1089-04, https://doi.org/10.1007/s12325-008-0113-z.
Roxburgh, P., & Evans, T. R. J. (2008). Systemic therapy of hepatocellular carcinoma: Are we making progress?. Advances in Therapy, 25(11), 1089-1104. https://doi.org/10.1007/s12325-008-0113-z
Roxburgh P, Evans TRJ. Systemic therapy of hepatocellular carcinoma: Are we making progress?. Advances in Therapy. 2008;25(11):1089-104.
Journal Categories
Medicine
Medicine (General)
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Hepatocellular Carcinoma: Interventional Bridging to Liver Transplantation Transplantation
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Surgery
  • Medicine: Surgery
  • Medicine: Medicine (General)
 33 2005
10.1016/S0168-8278(00)80427-4 Journal of Hepatology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
  • Medicine
  • Medicine: Medicine (General)
 2000
10.1056/NEJMoa0708857 New England Journal of Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2008
10.1200/JCO.2007.15.9947 2008
Randomized phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma Journal of Clinical Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 29 2008
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)79
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology42
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens25
Medicine15
Medicine: Internal medicine12
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine6
Medicine: Therapeutics. Pharmacology5
Medicine: Surgery4
Medicine: Public aspects of medicine: Toxicology. Poisons3
Medicine: Medicine (General): Medical technology2
Science: Biology (General): Cytology2
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry2
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Medicine: Pathology1
Science: Chemistry: Analytical chemistry1
Science: Chemistry1
Science: Biology (General)1
Science: Biology (General): Genetics1
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system1
The category Medicine: Medicine (General) 79 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p Molecular Biotechnology
  • Science: Biology (General)
  • Technology: Chemical technology: Biotechnology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2024
Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening

 Open Medicine
  • Medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 2024
Diagnosis of peritoneal metastasis in an unruptured hepatocellular carcinoma on ascitic fluid cytology: A rare scenario with brief review of literature

 Diagnostic Cytopathology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Medicine (General): Medical technology
  • Medicine: Pathology
  • Medicine: Medicine (General)
 2023
Molecular docking and molecular dynamics simulation analysis of bioactive compounds ofCichorium intybusL. seed against hepatocellular carcinoma Journal of Biomolecular Structure and Dynamics
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Physics
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 2023
SBRT vs. Y90

 American Journal of Clinical Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 2023
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)39
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens22
Science: Biology (General)9
Medicine: Public aspects of medicine: Toxicology. Poisons8
Science: Biology (General): Genetics8
Medicine: Therapeutics. Pharmacology7
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology6
Science: Biology (General): Cytology6
Medicine5
Science: Chemistry5
Medicine: Surgery5
Medicine: Internal medicine4
Technology: Chemical technology: Biotechnology4
Technology: Chemical technology4
Science: Chemistry: Organic chemistry: Biochemistry4
Science: Physics3
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials3
Science: Botany: Plant ecology2
Medicine: Other systems of medicine2
Science: Chemistry: General. Including alchemy2
Medicine: Medicine (General): Medical technology2
Medicine: Pathology2
Medicine: Dentistry1
Science1
Science: Science (General)1
Science: Chemistry: Physical and theoretical chemistry1
Technology: Chemical technology: Polymers and polymer manufacture1
Science: Chemistry: Organic chemistry1
Geography. Anthropology. Recreation: Environmental sciences1
Technology: Hydraulic engineering: River, lake, and water-supply engineering (General)1
Technology: Environmental technology. Sanitary engineering1
Science: Biology (General): Ecology1
Science: Chemistry: Analytical chemistry1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases1
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine1
The category Medicine: Medicine (General) 39 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Risk factors for postoperative recurrence of non‐B non‐C hepatocellular carcinoma and was published in 2009. The most recent citation comes from a 2024 study titled Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening. This article reached its peak citation in 2022, with 8 citations. It has been cited in 59 different journals, 18% of which are open access. Among related journals, the BMC Cancer cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year